VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 1016270
Sex: M
Age: 46
State: AZ

Vax Date: 02/07/2021
Onset Date: 02/07/2021
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies: None

Symptoms: Nausea and light headed on Feb 7, day of shot. Light headache and more severe muscle and join pain on Feb 8.

Other Meds: Multivitamin only.

Current Illness: None

ID: 1016271
Sex: F
Age: 77
State: OK

Vax Date: 01/21/2021
Onset Date: 01/30/2021
Rec V Date: 02/09/2021
Hospital:

Lab Data: I have photos from each day, but no tests were run.

Allergies: Flu vaccine, extreme hypersensitivity reaction in 1999. Effects lasted 8 months.

Symptoms: I observed an inflamed itchy area just below the injection site on Day 9. The inflammation broadened and spread downward over the next two days, reaching about 7 inches in length and 3 inches in width by Day 11. I consulted a dermatologist then. She recommended a double strength dose of Zyrtec and application of Triamcinolone ointment to the inflamed area. Over the next two days, this therapy halted the spread and reduced the inflammation, so that it was essentially gone by Day 13.

Other Meds: Livalo (pitavastatin) 5 mg every other day Estradiol vaginal cream, twice a week Citracal (calcium and Vitamin D3, twice a day

Current Illness: None

ID: 1016272
Sex: M
Age: 56
State: VA

Vax Date: 02/08/2021
Onset Date: 02/09/2021
Rec V Date: 02/09/2021
Hospital:

Lab Data: None

Allergies: Bee stings, I carry and EpiPen. MSG ingestion makes me terribly ill with a range of side effects; headache, loss of vertigo, optical migraines, and heart racing with PVCs.

Symptoms: Extreme dizziness and nausea

Other Meds: Lisinopril 20 mg once a day for high blood pressure

Current Illness: None

ID: 1016273
Sex: F
Age: 74
State:

Vax Date: 01/29/2021
Onset Date: 02/07/2021
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies: sulfa

Symptoms: COVID-19 Vaccine; Nine days after receiving the vaccine, I noticed slight soreness in the injection site muscle. When I got out of the shower the next morning, my arm had a red circle at the injection site. I had no other symptoms. The redness faded during the day. A friend of mine is a nurse who said I should report this, even though the symptoms were very mild. Later, I remembered scratching my arm before the redness occurred. My skin is dry during winter, so I hadn't made any connection to the vaccine site.

Other Meds: Lipitor, Synthroid, HCTZ, aspirin, vitamin D, CoQ10, Fosamax

Current Illness:

ID: 1016274
Sex: F
Age: 76
State: TX

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 02/09/2021
Hospital:

Lab Data: None

Allergies: Contrast dye-shortness of breath, rashes Hydrocodone, etc

Symptoms: Flushing of the face, tingling of the lips on date of shot 2/9/21.

Other Meds: Core, Lisinopril, Crestor, Levothyroxine OTC- Preservation

Current Illness: None

ID: 1016275
Sex: M
Age: 66
State: TX

Vax Date: 02/08/2021
Onset Date: 02/08/2021
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies: NSAID

Symptoms: Very bad injection site arm pain starting 4 pm 2/08 and continues. Sever chills started 2 am 2/09/21, stopped 8 am 2/09. Fever of 100 started about 5am 2/09 and continues. Very bad whole body aches started 1am 2/09 and continues.

Other Meds: Tramadol, Tylenol, Lyrica, Crestor, Isosorbide Din

Current Illness:

ID: 1016276
Sex: F
Age: 73
State: NV

Vax Date: 01/25/2021
Onset Date: 02/01/2021
Rec V Date: 02/09/2021
Hospital:

Lab Data: none

Allergies: None

Symptoms: One week after the shot I developed a small red itchy bump. It went away after 2 days. Then a week after that I developed a rash about 2 inches below the place where I received the shot. No bump, no itch, just a rash which is where I am right now.

Other Meds: daily vitamin for women over 50, Vitamin D, Vitamin E Atenolol, Triamt/HCTZ, Allopurinol, Furosemide, Potass CL CR, Metformin, Latanoprost eye drops

Current Illness: None

ID: 1016277
Sex: F
Age: 31
State: MI

Vax Date: 02/08/2021
Onset Date: 02/08/2021
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies: Codeine

Symptoms: My lips, face, and neck went tingly and semi-numb. It's a feeling similar to when your foot falls asleep.

Other Meds: Zoloft

Current Illness:

ID: 1016278
Sex: M
Age: 74
State: TN

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Shortness of breath and loss of consciousness about 10 hours after receiving vaccine.

Other Meds:

Current Illness:

ID: 1016279
Sex: F
Age: 30
State: PA

Vax Date: 02/03/2021
Onset Date: 02/04/2021
Rec V Date: 02/09/2021
Hospital:

Lab Data: None

Allergies: None

Symptoms: Experienced heat rash looking rash that appeared first on my torso then preceded to cover the rest of my body. Back, bilateral upper and lower extremities and lips. The rash is periodically itchy and inflamed. Benadryl 25mg daily at night with no relief.

Other Meds: None

Current Illness: None

ID: 1016280
Sex: F
Age: 37
State: OR

Vax Date: 01/30/2021
Onset Date: 02/07/2021
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies: Pollen fruit syndrome

Symptoms: Face swelling and sore arm 10 days after first shot

Other Meds: Lansoprazole, Aller-Tec

Current Illness: None

ID: 1016281
Sex: F
Age: 22
State: VA

Vax Date: 02/05/2021
Onset Date: 02/05/2021
Rec V Date: 02/09/2021
Hospital:

Lab Data: Scheduling an appointment with primary care and possibly allergist for allergy testing.

Allergies: Augmentin, Biaxin, grasses, weeds, trees, pet dander, sunflower seeds, sunflowers, sensitivities to pineapple

Symptoms: Tingling throughout arm and into shoulder blade on 2 occasions throughout the day. Eyes felt swollen a few hours after receiving vaccine between 1-2 pm. Symptoms went away. At around 11pm I got welts and hives all over my body but they were particularly prevalent at the vaccine site. No change in routine throughout the day nor a change in food. Largely went away by the next day around 1pm. Still experiencing slight itchiness.

Other Meds: Dulera, albuterol, Claritin

Current Illness: N/A

ID: 1016282
Sex: F
Age: 62
State: MI

Vax Date: 02/02/2021
Onset Date: 02/02/2021
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Systemic: Other- Eye quivering, heart raced, quickly returned to normal-Mild

Other Meds:

Current Illness:

ID: 1016289
Sex: M
Age: 58
State: OH

Vax Date: 02/02/2021
Onset Date: 02/03/2021
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies: None

Symptoms: Extreme joint and muscle pain, cluster headaches, fatigue, chills.

Other Meds: Buspirone, Escitalopram

Current Illness: None

ID: 1016295
Sex: F
Age: 38
State: OH

Vax Date: 02/04/2021
Onset Date: 02/04/2021
Rec V Date: 02/09/2021
Hospital:

Lab Data: NONE

Allergies: CECLOR

Symptoms: Bad headache Throwing up Severe chills Could barley walk and move Severe body aches Skin hurts so bad-wanted to rip it off Severe stomach pain Very sensitive to sound, lights and smells Vision blurry Fever

Other Meds: NONE

Current Illness: NONE

ID: 1016296
Sex: F
Age: 43
State: IA

Vax Date: 01/25/2021
Onset Date: 01/30/2021
Rec V Date: 02/09/2021
Hospital: Y

Lab Data: CRP 2/1 3.8, 2/2 <3, 2/3 <3 WBC 2/1 22K, 2/2 18.6, 2/4 17.2, 2/5 15.3, 2/6 16.7, 2/7 17.6 WBC differential 8-10% Lymph/88-90% Neutrophils; no band or eosinophils BC Neg x1 CMP all normal except elevated fasting glucose 123-137 2/5 d-dimer negative 2/2/2021: CD4/CD8 CD4 = 51%; absolute = 1212 CD8 = 15%; absolute = 359 Absolute lymphocytes= 2366 Helper/Suppressor ratio = 3.38 Only pending lab is random tryptase from 2/2/2021

Allergies: No Known Drug Allergies

Symptoms: Primarily pruritic rash. Started on the left arm near injection site. Exacerbated by day of onset of rash after spending time in a hot tub. Urticaria rash present prior to exposure to warm water. Urticaria at first even though 4 days after vaccination. Then started on right arm. Later spread to trunk, upper legs (anterior & posteriorly), then neck, scalp line (face spared, as were palms and soles of feet). Rash was distinct maculopapules, no pustules, no vesicles, no petechiae; + blanching. No other systemic symptoms, no other physical exam findings, + dermatographia. Started on medrol dose pack on 1/30/2021. Seen in ED on 2/1/2021 and hospitalized until 2/6. Seen in ED again 2/7/2021. Treatment History: 2/1 - 2/6/2021 Ceftriaxone 1 gm IVP on 2/1 Famotidine 20 mg IVP Q12 hrs Benadryl 50 mg IVP Q6 hrs prn Hydroxyzine oral prn Ativan oral prn Methylprednisolone 40 mg Q6 hrs x 4 doses, then 40 mg Q12 hrs x 3 days Discharged pn Prednisone 40 mg BID x 4 days, 30 mg BID x 4 days, 20 mg BID x 4 days, 10 mg BID x 4 days, 10 mg daily x 4 days Also given betamethasone dipropionate augmented 0.05% topically BID prn 2/7 Changed to zyrtec from hydroxyzine

Other Meds: fluoxetine 40 mg daily, zolpidem 5 mg HS

Current Illness: Had strept throat within the month prior to the vaccine

ID: 1016297
Sex: F
Age: 55
State: IA

Vax Date: 02/02/2021
Onset Date: 02/03/2021
Rec V Date: 02/09/2021
Hospital:

Lab Data: No lab test done

Allergies: PCN

Symptoms: Has dose #1 of Moderna on 1/3/2021 and about 1-1.5 weeks later developed rash. Rash resolved. Had dose #2 of Moderna on 2/2/2021 and about 24-48 hours later developed a hive like rash that worsened despite taking benadryl and zyrtec. Rash is from chest up to head. + itching. No fevers, No redness at injection site. Patient evaluated at clinic on 2/9/2021. Given Solu medrol and prednisone.

Other Meds: None

Current Illness: Denied

ID: 1016542
Sex: F
Age:
State: OH

Vax Date: 08/29/2020
Onset Date:
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Palpable area (2 cm) at injection site that is subcutaneous and tender; Palpable area (2 cm) at injection site that is subcutaneous and tender; Information has been received from FDA (VAERS # 842809) on 23-OCT-2020. This spontaneous report was received from a physician referring to a 12 years old White female patient. The patient's concurrent condition included achondroplasia. The patient was allergy to doxycycline, polmyxin. The patient's concomitant therapies included meningococcal acyw conj vaccine (dip toxoid) (MENACTRA) and diphtheria toxoid, pertussis acellular 5-component vaccine, tetanus toxoid (ADACEL). On 29-AUG-2020, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (manufacturer unknown) (manufacturer reported as ; lot # ARDE5523 is an invalid lot number for hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast). Lot number ARDE5523 does not match any Company product as confirmed by Lot Verification team) dose 1, intramuscular in the left arm for prophylaxis. In 2019, the patient experienced palpable area (2 cm) at injection site that was subcutaneous and tender. The outcome of both events reported as not recovered. The causality between the events and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (manufacturer unknown) was not provided. Follow-up information was received from the same reporter on 03-FEB-2021. The lot number of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (manufacturer unknown) was reported as 1602284 and it has been verified to be a valid lot number for hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast), expiration date not reported, but upon internal validation established as 26-SEP-2021. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: 1602284; expirationdate: 26-SEP-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; followupadditionalinfo :Yes; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent

Other Meds: MENACTRA; ADACEL; GARDASIL 9 SYRINGE (DEVICE)

Current Illness: Achondroplasia; Allergic reaction to antibiotics

ID: 1016543
Sex: M
Age: 4
State: WA

Vax Date: 12/17/2020
Onset Date: 12/17/2020
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: no documented reaction to receiving this vaccine; vaccine exposure, freezer left open; This spontaneous report has been received from a registered nurse and refers to 4-year-old male patient. The patient had no known allergies, no listed medical conditions and no illness at the time of the vaccination. His concomitant medication included diphtheria toxoid, pertussis acellular 5-component vaccine, poliovirus vaccine inactivated (mrc-5), tetanus toxoid (QUADRACEL). On 17-DEC-2020, the patients was vaccinated with improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) T023917 has been verified as a valid lot number, expiration date reported as 09-JAN-2022, first dose, via subcutaneous route in right arm for prophylaxis (exact dose was not reported). The excursion was due to the freezer was left open. It was reported that the vaccine was ok to use. It was unknown if the digital data logger was involved. The patient had no documented reaction to receiving this vaccine.; Sender's Comments: US-009507513-2012USA008918:

Other Meds: QUADRACEL

Current Illness:

ID: 1016544
Sex: U
Age:
State: ND

Vax Date:
Onset Date:
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Improperly stored administered Rotateq and Vaqta; This spontaneous report was received from a registered nurse concerning multiple unspecified patients of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided. On unknown dates, the patients were vaccinated with improperly stored hepatitis a vaccine, inactivated (VAQTA), lot number T014836 with expiration date 17-JUL-2021 (dose, strength, anatomical location and route of administration were not provided) and improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ), orally, lot number 1691141 with expiration date 01-NOV-2021 (dose, strength and anatomical location were not provided); both administered for prophylaxis. The temperature and timeframes were: below 36?F (33.8F) for 0 hours 28 minutes and 0 seconds, below 36?F (33.8F) for 7 hours 9 minutes and 0 seconds, below 36?F (33.4F) for 23 hours 59 minutes and 0 seconds and below 36?F (33.8F) for 24 hours 0 minutes and 0 seconds. All excursions were detected through data logger and was confirmed that were previous temperature excursions. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T014836; expirationdate: 17-JUL-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability

Other Meds: VAQTA SYRINGE (DEVICE)

Current Illness:

ID: 1016545
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: 66 year old patient who was inadvertently vaccinated with GARDASIL 9; No additional AE reported; This spontaneous report was received from a reporter of unspecified qualifications and refers to a 66-year-old male patient. His pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On an unknown date, the patient was inadvertently vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) lot # T008152, expiration date 21-JUN-2022 (formulation, strength, exact dose, anatomical location and route of administration were not reported) for prophylaxis (product administered to patient of inappropriate age). The outcome was not reported. No additional adverse event was reported. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T008152; expirationdate: 21-JUN-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability

Other Meds: GARDASIL 9 SYRINGE (DEVICE)

Current Illness:

ID: 1016546
Sex: M
Age: 14
State: NJ

Vax Date: 07/24/2019
Onset Date: 07/27/2020
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: No additional AE/PQC was reported; that the patient received his first dose of GARDASIL 9 when he was 14 years of age on 24-JUL-2019 and did not receive his second dose of GARDASIL 9 until he was 15 years of age on 27-JUL-2020; This spontaneous report was received from a patient's mother and refers to a 15-year-old male patient. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 24-JUL-2019, the patient received the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) intramuscular injection (dose, lot #, expiration date were not reported) to prevent human papilloma virus (HPV). On 27-JUL-2020, the patient received the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9). No adverse event was reported. The reporter asked if there were any other information on the dosing schedule of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) to support the patient receiving his second dose 3 days late.

Other Meds:

Current Illness:

ID: 1016547
Sex: U
Age:
State: IL

Vax Date: 01/25/2021
Onset Date: 01/25/2021
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: an improperly stored vaccine was administered; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's concomitant medication, pertinent medical history and drug allergies or reactions were not reported. On 25-JAN-2021, the patient was vaccinated with improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (strength and route of administration were not reported, lot # S035534 is an invalid lot # for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), lot # S035534 is a valid lot # for olmesartan medoxomil (OLMESARTAN), expiration date was reported as 04-NOV-2021) 1 injection (1 dosage form) for prophylaxis (product storage error). It was reported that the suspect vaccine was exposed to a temperature of above 9 degree Celsius (13.4 degree Celsius) for a time frame of 2 hours and 9 minutes, as recorded by the digital data logger. There were no previous temperature excursions.

Other Meds:

Current Illness:

ID: 1016548
Sex: U
Age:
State: IN

Vax Date: 02/05/2008
Onset Date:
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Shingles; ill defined disorder; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of an unknown age and gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 05-FEB-2008, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot #, expiration date, dose, dose # and route not specified) for the long-term prevention of singles and zoster-related conditions. Subsequently on an unknown date, the patient was treated for singles and other zoster related injuries( ill-defined disorder). The outcome of herpes zoster and ill-defined disorder was unknown. The reporter considered herpes zoster and ill-defined disorder to be related to Zoster Vaccine Live(ZOSTAVAX).

Other Meds:

Current Illness:

ID: 1016549
Sex: U
Age:
State: IN

Vax Date: 09/01/2019
Onset Date: 01/20/2021
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: no additional AE reported; inadvertently received a 3rd dose of VAQTA; This spontaneous report was received from a licensed practical nurse (LPN) and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant medications was provided. On an unknown date in September 2019, the patient was vaccinated with the first dose of hepatitis a vaccine, inactivated (VAQTA) prefilled syringe, lot # T017179 was confirmed to be valid, expiration date was 26-OCT-2021, 1 ml (route of administration and anatomical location were not reported) for prophylaxis. On an unknown date in November 2020, the patient was vaccinated with the second dose of hepatitis a vaccine, inactivated (VAQTA). On 20-JAN-2021 (also reported as two weeks ago), the patient was inadvertently vaccinated with the third dose of hepatitis a vaccine, inactivated (VAQTA) (inappropriate schedule of product administration). No additional adverse events was reported. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. devicelotnumber: T017179; expirationdate: 26-OCT-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability

Other Meds: VAQTA SYRINGE (DEVICE)

Current Illness:

ID: 1016550
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/09/2021
Hospital: Y

Lab Data:

Allergies:

Symptoms: faciaI swelling and blotches on her face.; faciaI swelling and blotches on her face.; This spontaneous report was received from a consumer via Pfizer and refers to a female patient of unknown age. The patient concurrent condition included "bad reaction to eggs". There was no information about the patient's concomitant therapies or medical history provided. On an unknown date in 1999, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (formulation, strength, dose, frequency, route of administration, indication, lot # and expiration date were not reported). On an unknown date in 1999, the patient had bad reaction to an measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) vaccine, that resulted in faciaI swelling and blotches on her face. The patient was admitted to the hospital on an unknown date. The outcome of swelling face and rash macular was unknown. The reporter considered swelling face and rash macular to be related to Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live(M-M-R II).

Other Meds:

Current Illness: Food allergy

ID: 1016551
Sex: M
Age:
State: IL

Vax Date: 04/12/2013
Onset Date:
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: hearing loss; herpes zoster; Bell's palsy/facial paralysis; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or around 12-APR-2013, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose and route of administration were not reported) for routine health maintenance an for its intended purpose: the prevention of shingles (herpes zoster). On an unknown date, reported as after receiving zoster vaccine live (ZOSTAVAX), the patient suffered herpes zoster, Bell's palsy, hearing loss and facial paralysis. As a result of these symptoms, the patient was seen and treated by medical providers and was still under their care. As a direct and proximate result of zoster vaccine live (ZOSTAVAX) vaccine, patient's symptoms have resulted in physical limitations not present prior to using zoster vaccine live (ZOSTAVAX). The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of his condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of Company's wrongful conduct, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of Company's conduct, the patient had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of herpes zoster, Bell's palsy, hearing loss and facial paralysis was reported as not recovered. The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX). The events of herpes zoster, Bell's palsy, hearing loss and facial paralysis were considered to be disabling. Upon internal review, the events of Bell's palsy/facial paralysis and hearing loss were considered to be medically significant.

Other Meds:

Current Illness: Routine health maintenance

ID: 1016552
Sex: F
Age:
State:

Vax Date: 10/01/2020
Onset Date:
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: achiness; soreness at site of vaccination; shivering/ chills; headache; fever; vomiting; Diarrhea; This case was reported by a consumer via other manufacturer and described the occurrence of pain in a 57-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2020-2021 season) for prophylaxis. Previously administered products included Shingrix with an associated reaction of pain (1st dose received in July 2020, refer case US2020AMR254715). Concurrent medical conditions included egg allergy. In October 2020, the patient received the 2nd dose of Shingrix and Influenza vaccine Quadrivalent 2020-2021 season. On an unknown date, less than 3 months after receiving Shingrix and Influenza vaccine Quadrivalent 2020-2021 season, the patient experienced pain, injection site pain, shivering, headache, fever, vomiting and diarrhea. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the pain, injection site pain, shivering, headache, fever, vomiting and diarrhea were unknown. It was unknown if the reporter considered the pain, injection site pain, shivering, headache, fever, vomiting and diarrhea to be related to Shingrix and Influenza vaccine Quadrivalent 2020-2021 season. Additional details were provided as follows: The age at vaccination was not reported, however could be 56 or 57 years. The patient received Shingrix vaccine and Flu vaccine on same day. The patient reported experienced every adverse reaction possible. The symptoms listed were achiness, soreness at site of vaccination, chills, shivering, headache, fever, vomiting, and diarrhea. The reporter consent to call her back.; Sender's Comments: US-GLAXOSMITHKLINE-US2020AMR254715:same reporter, 1st dose

Other Meds:

Current Illness: Egg allergy

ID: 1016553
Sex: F
Age:
State: ME

Vax Date: 11/06/2020
Onset Date: 11/01/2020
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: I was having trouble moving my head and arms without pain that makes you want to cry; scratchy throat; tired; muscle pain not too bad but not great; severe headache / having trouble moving my head / without pain that makes you want to cry; pain in both arms / trouble moving my/ arms / without pain that makes you want to cry; neck and pain; upset stomach; shaking; This case was reported by a consumer and described the occurrence of throat irritation in a 55-year-old female patient who received Herpes zoster SHINGRIX. Concurrent medical conditions included thyroid hormones decreased and multiple allergies. On 6th November 2020, the patient received the 1st dose of SHINGRIX .5 ug. On 14th November 2020, 8 days after receiving SHINGRIX, the patient experienced mobility decreased. In November 2020, the patient experienced throat irritation, tiredness, muscle pain, headache, pain in arm, neck pain, upset stomach and tremor. On an unknown date, the outcome of the throat irritation, tiredness, muscle pain, headache, pain in arm, neck pain, upset stomach, tremor and mobility decreased were recovered/resolved. The reporter considered the throat irritation, tiredness, muscle pain, headache, pain in arm, neck pain, upset stomach, tremor and mobility decreased to be related to SHINGRIX. Additional details were provided as follows: The patient had multiple allergies and take medicines for low thyroid. Age at vaccination was not reported. Age group was captured as adult as per product indication. The patient received SHINGRIX on right arm. Reaction started with scratchy throat, tired and muscle pain not too bad but not great. It escalated during the week with severe headache, neck and pain in both arms, upset stomach. By Saturday night on 14th November 2021 the patient had trouble moving head and arms without pain that makes want to cry. It started to ease up Monday the 16th but the patient did call doctor. The patient continued to feel milder symptoms until the next Sunday.

Other Meds:

Current Illness: Thyroid hormones decreased

ID: 1016554
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: headache; soreness; This case was reported by a consumer via interactive digital media and described the occurrence of headache in a adult patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced headache and pain. On an unknown date, the outcome of the headache and pain were unknown. The reporter considered the headache and pain to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not reported. The age group of patient was not reported but captured as an adult as per vaccine indication. The patient was vaccinated with Shingrix and experienced headache and soreness. The patient was asked if to take Tylenol or Advil for headache and soreness.

Other Meds:

Current Illness:

ID: 1016555
Sex: U
Age:
State:

Vax Date: 07/01/2020
Onset Date:
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Arm soreness; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a adult patient who received Herpes zoster (Shingrix) for prophylaxis. In July 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 5 months after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved. It was unknown if the reporter considered the pain in arm to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not reported. The age group of patient was not reported but was captured as an adult as per vaccine indication. The patient was vaccinated with 1st dose of Shingrix 5 months ago from reporting day since then patient had arm soreness. Till time of reporting arm soreness was not resolved. The patient's physician never heard of this happening. The patient was scheduled to get the 2nd shot on reporting day.

Other Meds:

Current Illness:

ID: 1016556
Sex: U
Age:
State:

Vax Date: 12/01/2020
Onset Date: 12/01/2020
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Nurse or PA said take Tylenol for pain. Tylenol did not work; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis. In December 2020, the patient received the 1st dose of Shingrix. In December 2020, less than a week after receiving Shingrix, the patient experienced pain. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the pain was not recovered/not resolved. It was unknown if the reporter considered the pain to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not reported. The age group of patient was not reported but was captured as an adult as per vaccine indication. The reporter stated that the nurse or PA told patient to take Tylenol for pain and do not take Advil. The patient stated Tylenol did not help and asked if the patient could take Advil.

Other Meds:

Current Illness:

ID: 1016557
Sex: U
Age:
State:

Vax Date: 11/20/2020
Onset Date:
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Still have the red discoloration at the site of injection; This case was reported by a consumer and described the occurrence of injection site erythema in a adult patient who received Herpes zoster (Shingrix) for prophylaxis. On 20th November 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 weeks after receiving Shingrix, the patient experienced injection site erythema. On an unknown date, the outcome of the injection site erythema was not recovered/not resolved. It was unknown if the reporter considered the injection site erythema to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not reported. The age group at vaccination was not reported but was captured as an adult as per vaccine indication. The patient received Shingrix and experienced red discoloration at the site of injection. Till the time of reporting symptom was not resolved. The patient was asked to take the 2nd shot on same injection site or not.

Other Meds:

Current Illness:

ID: 1016558
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: My friend's daughter/ got the vaccine / has Polycystic Ovarian Syndrome; This case was reported by a consumer via interactive digital media and described the occurrence of polycystic ovarian syndrome in a 19-year-old female patient who received HPV 16-18 (HPV vaccine) for prophylaxis. On an unknown date, the patient received HPV vaccine. On an unknown date, 7 years after receiving HPV vaccine, the patient experienced polycystic ovarian syndrome. On an unknown date, the outcome of the polycystic ovarian syndrome was not recovered/not resolved. It was unknown if the reporter considered the polycystic ovarian syndrome to be related to HPV vaccine. Additional information was provided as follows: The patient received HPV vaccine and experienced polycystic ovarian syndrome. The reporter mentioned that, HPV vaccine had been used to sterilize the girls and she wished, she could have known this 7 years ago. The case is linked with the case number- US2020AMR247399, reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2020AMR247399:same reporter

Other Meds:

Current Illness:

ID: 1016559
Sex: U
Age:
State:

Vax Date: 12/10/2020
Onset Date: 12/17/2020
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: strong burning sensation where I have had the Shingles; This case was reported by a consumer and described the occurrence of burning sensation in face in a adult patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included shingles (on the face, around left nostril and upper lip left side for 8 years). On 10th December 2020, the patient received the 1st dose of Shingrix. On 17th December 2020, 7 days after receiving Shingrix, the patient experienced burning sensation in face. On an unknown date, the outcome of the burning sensation in face was not recovered/not resolved. It was unknown if the reporter considered the burning sensation in face to be related to Shingrix. Additional details were provided as follows: The age group was not reported, however it was captured as an adult as per vaccine indication. The age at vaccination was not reported. The had shingles on my face for 8 years now around the left nostril and upper lip left side. The patient recently got the Shingrix vaccination a week ago from the time of reporting as approved by the physician and on the day of reporting the patient was having strong burning sensation where he/she had the shingles.

Other Meds:

Current Illness: Shingles (on the face, around left nostril and upper lip left side for 8 years)

ID: 1016560
Sex: U
Age:
State: NC

Vax Date:
Onset Date:
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Chills; arm pain at site of inj; achy; nauseous; This case was reported by a consumer and described the occurrence of chills in a 64-year-old patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced chills, pain in arm, pain and nausea. On an unknown date, the outcome of the chills, pain in arm, pain and nausea were unknown. It was unknown if the reporter considered the chills, pain in arm, pain and nausea to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not reported, however it could be 63 or 64 years. The patient asked how long may typical non-dangerous side effect last from Shingrix vaccine. The patient had the first or 2nd Shingrix vaccine. The patient enquired how long might typical side effects last. The patient was experiencing side effects, was achy nauseous usually the side area from shots, chills and typical arm pain at site of injection.

Other Meds:

Current Illness:

ID: 1016561
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Got a red papule; This case was reported by a consumer via interactive digital media and described the occurrence of papule in a adult patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced papule. On an unknown date, the outcome of the papule was unknown. It was unknown if the reporter considered the papule to be related to Shingrix. Additional details were provided as follows: The age group was not reported, however it was captured as an adult as per vaccine indication. The age at vaccination was not reported. The patient got a red papule with the second Shingrix vaccine. The patient asked if this was normal.

Other Meds:

Current Illness:

ID: 1016562
Sex: F
Age:
State: CT

Vax Date: 09/10/2020
Onset Date: 09/01/2020
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: unusual reaction to the first dose; odd sensation in the upper arm muscle / occasional numbness / most pronounced when my arm was on the steering wheel or / relatively stationary position; This case was reported by a consumer and described the occurrence of numbness of upper extremities in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included penicillin allergy. On 10th September 2020, the patient received Shingrix. In September 2020, less than a month after receiving Shingrix, the patient experienced numbness of upper extremities. On an unknown date, the patient experienced adverse reaction. On an unknown date, the outcome of the numbness of upper extremities was not recovered/not resolved and the outcome of the adverse reaction was unknown. It was unknown if the reporter considered the numbness of upper extremities and adverse reaction to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not reported. After receiving Shingrix, the patient was still experiencing an odd sensation in the upper arm muscle. The occurrence of this occasional numbness had diminished, sometime since September 2020 but till the time of reporting, it was still reoccurred daily. At first it was most pronounced when her arm was on the steering wheel or in a relatively stationary position for extended lengths of time. The patient reported that, the Shingrix website had no information that she could find on long term side effects. The patient's concerns were that taking a 2nd dose might exaggerate this condition. The patient would like to know how effective in preventing shingles in one dose of Shingrix. She asked if she choose to take a second dose can could she have the injection in her other arm. The patient also reported that, she had an unusual reaction to the first dose. She was asking how effective one dose of Shingrix was.

Other Meds:

Current Illness: Penicillin allergy

ID: 1016563
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: hives; This case was reported by a consumer and described the occurrence of hives in a adult patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced hives. On an unknown date, the outcome of the hives was unknown. It was unknown if the reporter considered the hives to be related to Shingrix. Additional details were provided as follows: Age at vaccination was not reported. Age group was captured as adult as per product indication. The reporter reported that are hives after Shingrix normal. Due to insufficient information hives was consider as event.

Other Meds:

Current Illness:

ID: 1016564
Sex: F
Age: 65
State: MN

Vax Date: 12/27/2020
Onset Date: 12/27/2020
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: tingly arm; suspect that only about half the dose was given; This case was reported by a pharmacist and described the occurrence of tingling of extremity in a 65-year-old female patient who received Herpes zoster (Shingrix) (batch number 53X42, expiry date unknown) for prophylaxis. On 27th December 2020, the patient received the 1st dose of Shingrix. On 27th December 2020, less than a day after receiving Shingrix, the patient experienced tingling of extremity and accidental underdose. On an unknown date, the outcome of the tingling of extremity and accidental underdose were unknown. It was unknown if the reporter considered the tingling of extremity to be related to Shingrix. Additional details were provided as follows: The reporter was giving the Shingrix vaccine to the patient, and quite a lot of liquid squirted out the sides of the plastic part of the needle, which led to accidental underdose. The reporter suspected that only about half the dose was given. The patient's arm felt tingly. The reporter asked for recommendation to give another dose or to give half dose or to wait until the next dose was due or other. On 28th December 2020, the reporter called for information regarding the administration of less than the recommended dose of Shingrix to a patient. The patient received around half a dose of Shingrix due to a needle leakage. The reporter consented to follow up.; Sender's Comments: US-GLAXOSMITHKLINE-US2020256888:FU1 deleted

Other Meds:

Current Illness:

ID: 1016565
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: developed a red patch from shot site developed a red patch / to under my arm; Was swollen on part of it; This case was reported by a consumer and described the occurrence of erythema of extremities in a adult patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced erythema of extremities and local swelling. On an unknown date, the outcome of the erythema of extremities and local swelling were unknown. It was unknown if the reporter considered the erythema of extremities and local swelling to be related to Shingrix. Additional details were provided as follows: The age group was not reported, however it was captured as an adult as per vaccine indication. The age at vaccination was not reported. The patient had a shingle shot and developed a red patch from shot site to under the arm, it was swollen on part of it. The patient asked it there was anything to worry about. The patient would be due for the second shot soon and had signed up for COVID shot at the end of December.

Other Meds:

Current Illness:

ID: 1016566
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: red patch from shingle shot site to under arm; This case was reported by a consumer and described the occurrence of erythema of extremities in a adult patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced erythema of extremities. On an unknown date, the outcome of the erythema of extremities was unknown. It was unknown if the reporter considered the erythema of extremities to be related to Shingrix. Additional details were provided as follows: The age group was not reported, however it was captured as an adult as per vaccine indication. The age at vaccination was not reported. The patient had red patch from shingle shot site to under arm. The patient asked if there was anything to worry about.

Other Meds:

Current Illness:

ID: 1016567
Sex: U
Age:
State:

Vax Date: 12/23/2020
Onset Date: 12/23/2020
Rec V Date: 02/09/2021
Hospital:

Lab Data: Test Date: 20201224; Test Name: body temperature; Result Unstructured Data: (Test Result:99.9,Unit:degree F,Normal Low:,Normal High:)

Allergies:

Symptoms: temperature is 99.9; shoulder was sore/ Joint pain; chills; This case was reported by a consumer and described the occurrence of shoulder soreness in a adult patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix with an associated reaction of no adverse event (1st dose received on unknown date). On 23rd December 2020, the patient received the 2nd dose of Shingrix. On 23rd December 2020, less than a day after receiving Shingrix, the patient experienced shoulder soreness and chills. On 24th December 2020, the patient experienced fever. On an unknown date, the outcome of the shoulder soreness and chills were unknown and the outcome of the fever was not recovered/not resolved. It was unknown if the reporter considered the shoulder soreness, chills and fever to be related to Shingrix. Additional details were provided as follows: The age group was not reported, however it was captured as an adult as per vaccine indication. The age at vaccination was not reported. The patient received the Shingle vaccine a day before reporting. The patient's shoulder was sore on the same day and later had joint pain and chills. At the time of reporting the patient's temperature is 99.9 degrees F. The patient asked if this was a side effect of the vaccine.

Other Meds:

Current Illness:

ID: 1016568
Sex: M
Age:
State:

Vax Date:
Onset Date: 04/01/2020
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: transient lower extremity weakness; This case was reported by a consumer and described the occurrence of lower extremities weakness of in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingrix. In April 2020, 2 weeks after receiving Shingrix, the patient experienced lower extremities weakness of. On an unknown date, the outcome of the lower extremities weakness of was resolved with sequelae. It was unknown if the reporter considered the lower extremities weakness of to be related to Shingrix. Additional details were provided as follows: The reporter was inquiring because an acquaintance experienced this symptom two weeks out from the second inject of Shingrix. The event occurred around April 2020. The weakness was transient. The reporter asked if there were any reports of transient lower extremity weakness with Shingrix. The reporter personally did not believe if there was a correlation but wanted to see if it had been reported during trials and follow up. The patient was concerned now only because of the possibility of taking the COVID vaccine. The reporter did not consent to follow up.; Sender's Comments: US-GLAXOSMITHKLINE-US2021003169:same reporter

Other Meds:

Current Illness:

ID: 1016569
Sex: F
Age:
State: CT

Vax Date: 01/13/2020
Onset Date:
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Skin reaction; severe bruising; January 13th 2020 and therefore the second dose was not administered; This case was reported by a pharmacist and described the occurrence of skin reaction in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. On 13th January 2020, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced skin reaction, contusion and incomplete course of vaccination. On an unknown date, the outcome of the skin reaction was recovered/resolved and the outcome of the contusion and incomplete course of vaccination were unknown. It was unknown if the reporter considered the skin reaction and contusion to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not reported. After receiving Shingrix, the patient experienced skin reaction with severe bruising. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete vaccination schedule. The reporter did not consent to follow-up.

Other Meds:

Current Illness:

ID: 1016570
Sex: U
Age:
State: OK

Vax Date:
Onset Date:
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: shingles; This case was reported by a nurse and described the occurrence of shingles in a adult patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to Shingrix. Additional details were provided as follows: The age group was not reported but was captured as adult as per the vaccine indication. After receiving Shingrix, then in the waiting period for the 2nd vaccine, they developed shingles. The reporter asked, how long until they could have the second dose. The reporter did not consent to follow up. No additional information available and no permission for follow up.

Other Meds:

Current Illness:

ID: 1016571
Sex: F
Age:
State: AZ

Vax Date:
Onset Date:
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: kicked her butt; This case was reported by a pharmacist and described the occurrence of feeling unwell in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose on an unknown date). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced feeling unwell. On an unknown date, the outcome of the feeling unwell was unknown. It was unknown if the reporter considered the feeling unwell to be related to Shingrix. Additional details were provided as follows: The reporter was the patient's pharmacy friend. The patient born about in 1966. The age at vaccination was not reported. The patient received Shingrix in year 2020. The reporter stated that the 2nd dose of Shingrix kicked the patient's butt. The reporter consented to follow up. No further information available but agreeable to contact by email. This was 1 of 3 linked cases reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2020246485:same reporter US-GLAXOSMITHKLINE-US2020246486:same reporter

Other Meds:

Current Illness:

ID: 1016572
Sex: M
Age:
State: AZ

Vax Date:
Onset Date:
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: kicked his butt; This case was reported by a pharmacist and described the occurrence of feeling unwell in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose on an unknown date). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced feeling unwell. On an unknown date, the outcome of the feeling unwell was unknown. It was unknown if the reporter considered the feeling unwell to be related to Shingrix. Additional details were provided as follows: The reporter was the patient's pharmacy friend. The patient born about in 1966. The age at vaccination was not reported. The patient received Shingrix in year 2020. The reporter stated that the 2nd dose of Shingrix kicked the patient's butt. The reporter consented to follow up. No further information was available but agreeable to contact by email. This was 1 of 3 linked cases reported by the same reporter. Sender's Comments: US-GLAXOSMITHKLINE-US2020246486:same reporter US-GLAXOSMITHKLINE-US2020246482:same reporter

Other Meds:

Current Illness:

ID: 1016573
Sex: F
Age: 50
State: IL

Vax Date: 02/11/2020
Onset Date: 02/13/2020
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: feeling wiped out two days; This case was reported by a consumer and described the occurrence of worn out in a 50-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 11th February 2020, the patient received the 1st dose of Shingrix. On 13th February 2020, 2 days after receiving Shingrix, the patient experienced worn out. On an unknown date, the outcome of the worn out was recovered/resolved. It was unknown if the reporter considered the worn out to be related to Shingrix. Additional details were reported as follows: The patient received Shingrix and 2 days after expereinced feeling wiped out. The reporter reported that till the time of report felt fine. The reporter did not consent to follow up.

Other Meds:

Current Illness:

ID: 1016574
Sex: F
Age: 64
State: PA

Vax Date: 10/22/2020
Onset Date:
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: severe muscles aches which lasted 3 weeks; This case was reported by a pharmacist and described the occurrence of myalgia in a 64-year-old female patient who received Herpes zoster (Shingrix) (batch number KY5T4, expiry date unknown) for prophylaxis. On 22nd October 2020, the patient received the 1st dose of Shingrix (intramuscular). On 22nd October 2020, less than a day after receiving Shingrix, the patient experienced myalgia. On an unknown date, the outcome of the myalgia was recovered/resolved. It was unknown if the reporter considered the myalgia to be related to Shingrix. Additional details were provided as follows: After receiving Shingrix, the patient had severe muscle aches. The reporter did not consent to follow up.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm